Azura raises $16M in series B

On Oct. 10, dry eye disease company Azura Ophthalmics Ltd. (Tel Aviv, Israel) said it raised $16 million in a series B round led by OrbiMed, TPG Biotech and Brandon Capital’s Medical Research Commerc...